FISONS INVESTING $150 MIL. IN NEW MANUFACTURING FACILITY
Executive Summary
FISONS INVESTING $150 MIL. IN NEW MANUFACTURING FACILITY over the next four years in conjunction with a plan to improve efficiency at the company's Pharmaceutical Division. Fisons plc announced the capital spending project on Jan. 25. Construction of the new facility is expected to begin in late 1994 at Fisons' principal manufacturing site, Holmes Chapel in Cheshire, England. Fisons will continue to manufacture asthma inhalers and several other anti-allergy pharmaceuticals at Holmes Chapel; the new facility will be designed to produce non-chlorofluorocarbon products.